Article
Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage
9 Jun 2014
Abstract excerpt
Platinum drugs are a mainstay of anticancer chemotherapy. Nevertheless, tumors often display inherent or acquired resistance to platinum-based treatments, prompting the search for new compounds that do not exhibit cross-resistance with current therapies. Phenanthriplatin, cis-diamminephenanthridinechloroplatinum(II), is a potent monofunctional platinum complex that displays a spectrum of activity distinct from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
